International Journal of Trichology International Journal of Trichology
 Print this page Email this page Small font sizeDefault font sizeIncrease font size
  Home | About IJT | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submission | Subscribe | Advertise | Contact us | Login   

    Article Cited by others


Finasteride induced gynecomastia: Case report and review of the literature

Ramot Yuval, Czarnowicki Tali, Zlotogorski Abraham

Year : 2009| Volume: 1| Issue : 1 | Page no: 27-29

   This article has been cited by
1 NUDT5 as a novel drug target and prognostic biomarker for ER-positive breast cancer
Xin-Yu Tong, Yuan Quan, Hong-Yu Zhang
Drug Discovery Today. 2021; 26(3): 620
[Pubmed]  [Google Scholar] [DOI]
2 Coenzyme Q10 phospholipidic vesicular formulations for treatment of androgenic alopecia: ex vivo permeation and clinical appraisal
Ghada M. El-Zaafarany, Rasha T.A. Abdel-Aziz, Mahmoud Hamdy Ahmed Montaser, Maha Nasr
Expert Opinion on Drug Delivery. 2021; 18(10): 1513
[Pubmed]  [Google Scholar] [DOI]
3 Reduction of telogen rate and increase of hair density in androgenetic alopecia by a cosmetic product: Results of a randomized, prospective, vehicle-controlled double-blind study in men
Julia Welzel, Helmut H. Wolff, Wolfgang Gehring
Journal of Cosmetic Dermatology. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Identification of NUDT5 Inhibitors From Approved Drugs
Xin-Yu Tong, Xuan Liao, Min Gao, Bo-Min Lv, Xiao-Hui Chen, Xin-Yi Chu, Qing-Ye Zhang, Hong-Yu Zhang
Frontiers in Molecular Biosciences. 2020; 7
[Pubmed]  [Google Scholar] [DOI]
5 Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double-blind, randomized controlled trial study
Farid Masoud, Hamideh Azimi Alamdari, Solmaz Asnaashari, Javad Shokri, Yousef Javadzadeh
Dermatologic Therapy. 2020; 33(6)
[Pubmed]  [Google Scholar] [DOI]
6 The Androgenic Alopecia Protective Effects of Forsythiaside-A and the Molecular Regulation in a Mouse Model
Heon-Sub Shin,Sang-Yong Park,Hyun-Geun Song,Eunson Hwang,Don-Gil Lee,Tae-Hoo Yi
Phytotherapy Research. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
7 Gynecomastia and drugs: a critical evaluation of the literature
Frank Q. Nuttall,Rohit S. Warrier,Mary C. Gannon
European Journal of Clinical Pharmacology. 2015; 71(5): 569
[Pubmed]  [Google Scholar] [DOI]
8 5a-Reductase inhibitors in androgenetic alopecia
Elizabeth Yim,Katherine L. Baquerizo Nole,Antonella Tosti
Current Opinion in Endocrinology & Diabetes and Obesity. 2014; 21(6): 493
[Pubmed]  [Google Scholar] [DOI]
9 Drug-induced gynecomastia
Bowman, J.D. and Kim, H. and Bustamante, J.J.
Pharmacotherapy. 2012; 32(12): 1123-1140
[Pubmed]  [Google Scholar]
10 Topical melatonin for treatment of androgenetic alopecia
Fischer, T. and Trüeb, R. and Hänggi, G. and Innocenti, M. and Elsner, P.
International Journal of Trichology. 2012; 4(4): 236-245
[Pubmed]  [Google Scholar]
11 Drug-Induced Gynecomastia
John D. Bowman,Hyunah Kim,Juan J. Bustamante
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2012; 32(12): 1123
[Pubmed]  [Google Scholar] [DOI]
12 Topical melatonin for treatment of androgenetic alopecia [Melatonin in der topischen Behandlung der androgenetischen Alopezie]
Fischer, T.W. and Trüeb, R.M. and Hänggi, G. and Innocenti, M. and Elsner, P.
Aktuelle Dermatologie. 2011; 37(11): 410-418
[Pubmed]  [Google Scholar]
13 Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders
Paba, S. and Frau, R. and Godar, S.C. and Devoto, P. and Marrosu, F. and Bortolato, M.
Current Pharmaceutical Design. 2011; 17(2): 151-167
[Pubmed]  [Google Scholar]


Read this article